(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

122020010667

Concessão AnuladaUtility ModelPCT · US2007081098

Application data

Number

122020010667

Type

Utility Model

Filing

10/11/2007

Publication

-

PCT

US2007081098

Progress at the INPI

  1. Filing10/11/07
  2. Publication
  3. Examination
  4. Allowance12/29/20
  5. Grant03/09/21
  6. In force10/11/22

The patent was granted on 03/09/2021 and is in force until 10/11/2022. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.

Protection valid until:10/11/2022

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 07/27/2021. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

DECIPHERA PHARMACEUTICALS LLC

US

See this company's full portfolio

Inventors

D. F. (pessoa física)

US

M. K. (pessoa física)

US

P. P. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

11/870,388 · 10/10/2007

US

60/850,834 · 10/11/2006

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

16.3

Prazo de Validade: 20 (vinte) anos contados a partir de 11/10/2007, observadas as condições legais. Patente concedida conforme ADI 5.529/DF, que determina a alteração do prazo de concessão

07/27/2021

RPI 2638

Concessão da patente

#16.1

10 (dez) anos contados a partir de 09/03/2021, observadas as condições legais

03/09/2021

RPI 2618

Deferimento

#9.1

12/29/2020

RPI 2608

Exigência - art. 36 da LPI

#6.1

09/15/2020

RPI 2593

Notificação de pedido dividido

#2.4

Dividido do PI 0719195-2

08/25/2020

RPI 2590

Requerimento de pedido de patente

#2.10

Número de Protocolo '870200065789' em 27/05/2020 17:21 (WB)

07/14/2020

RPI 2584

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.